Morning Briefing
Summaries of health policy coverage from major news organizations
HIV Prevention Drug Receives FDA Panel's Backing
The drug, which has already been approved as a treatment for HIV/AIDS, received the endorsement of a panel of Food and Drug Administration advisers to also use it to prevent the HIV infection. The FDA is expected to make its final decision on approval by June 15, and the agency is not bound to follow the expert panel's recommendation.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
